<?xml version="1.0" encoding="UTF-8"?>
<p>The patient was admitted to our hospital because of palpitation and shortness of breath for three days, and diagnosed with atrial fibrillation and heart failure, with cardiac function NYHA grade III at Northern Jiangsu People’s Hospital on March 21, 2018. He had a CHA
 <sub>2</sub>DS
 <sub>2</sub>-VASc score of 4, which indicated a high risk of stroke. His body mass index was 21.66 kg/m
 <sup>2</sup>, and renal function was normal. Therefore, he was given furosemide and spironolactone for diuretic therapy, valsartan capsules for antihypertensive treatment, and LMWH for anticoagulation therapy.
</p>
